For-Profit or Non-Profit? That is the ($100-Billion) Question
Panel Discussion
HealthcareInsightsInvestmentLegislationMental HealthRegulation
Information
Rick Doblin, Founder and Executive Director of the Multidisciplinary Association of Psychedelic Studies (MAPS) will be joined by Christian Angermayer, Founder of atai Life Sciences, to discuss how for-profit and non-profit psychedelic organisations can co-exist and achieve objectives in today’s increasingly competitive business landscape.